Marketing-authorisation holder · United States
Roche
57 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
57 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 57
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ARFONAD50mg/ml · Injectable | Trimethaphan camsylate | United States | Not marketed | 1954 |
| AZO GANTANOL100MG; 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Phenazopyridine, Sulfamethoxazole | United States | Not marketed | |
| AZO GANTRISIN50MG; 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Phenazopyridine, Sulfafurazole | United States | Not marketed | 1990 |
| BEROCCA PN50mg/ml; 0.03mg/ml; 0.0025mg/ml; 7.5mg/ml; 100 iu/ml; 0.2mg/ml; 20mg/ml; 2mg/ml; 5'-phosphate sodium 1.8mg/ml; 1.5mg/ml; 1,650 iu/ml; 5 iu/ml · Injectable | Ascorbic acid, Biotin, Vitamin b12, Dexpanthenol, Ergocalciferol, Folic acid, Niacinamide, Vitamin b6, Vitamin b2, Vitamin b1, Vitamin a palmitate, Vitamin e | United States | Not marketed | 1947 |
| BONIVA3MG BASE/3ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Ibandronic acid | United States | Not marketed | 2006 |
| COACTIN1gm/vial | 250mg/vial | 500mg/vial · Injectable | Amdinocillin | United States | Not marketed | |
| COPEGUS200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ribavirin | United States | Not marketed | 2002 |
| DEMADEX20MG/2ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 50MG/5ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Torasemide | United States | Not marketed | 1993 |
| ENDEP40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Concentrate | Amitriptyline | United States | Not marketed | |
| ENDEP100mg | 10mg | 150mg | 25mg | 50mg | 75mg · Tablet | Amitriptyline | United States | Not marketed | 1976 |
| FANSIDAR25mg; 500mg · Tablet | Pyrimethamine, Sulfadoxine | United States | Not marketed | 1981 |
| FUZEON90mg/vial · Injectable | Enfuvirtide | United States | Not marketed | 2003 |
| GANTANOL500mg · Tablet | Sulfamethoxazole | United States | Not marketed | 1965 |
| GANTANOL500mg/5ml · Suspension | Sulfamethoxazole | United States | Not marketed | 1965 |
| GANTANOL-DS1GM · Tablet | Sulfamethoxazole | United States | Not marketed | 1965 |
| GANTRISIN500mg base/5ml · Syrup | Sulfisoxazole acetyl | United States | Not marketed | 1953 |
| GANTRISIN400mg base/ml · Injectable | Sulfisoxazole diolamine | United States | Not marketed | |
| GANTRISIN500mg · Tablet | Sulfafurazole | United States | Not marketed | 1948 |
| GANTRISIN4% base · Ointment | Sulfisoxazole diolamine | United States | Not marketed | |
| GANTRISIN4% base · Solution/drops | Sulfisoxazole diolamine | United States | Not marketed | |
| GANTRISIN PEDIATRIC500mg base/5ml · Suspension | Sulfisoxazole acetyl | United States | Not marketed | 1953 |
| HIVID0.375mg | 0.75mg · Tablet | Zalcitabine | United States | Not marketed | 1992 |
| KLONOPIN RAPIDLY DISINTEGRATING0.125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 0.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1MG **Federal Regis · Tablet, orally disintegrating | Clonazepam | United States | Not marketed | 1997 |
| KONAKION10mg/ml | 1mg/0.5ml · Injectable | Phytonadione | United States | Not marketed | |
| KYTRIL2MG BASE/10ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Granisetron | United States | Not marketed | 2001 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 57 | 57 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.